Not applicableUnknownNCT02000310What this trial is testingMolecular and Cellular Mechanisms of Lysosomal Storage DiseasesWho this might be right forLysosomal Storage Disorders O & O Alpan LLC 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT06770426What this trial is testingCompARing Between CO2 Phenylephrine and Phenylephrine Only Treatment in Patients With proGrEssing Cerebral infarctioNWho this might be right forAcute Ischemic Stroke Yonsei University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06819514What this trial is testingThe Safety and Efficacy of Intravenous EXG110 in Patients With Fabry DiseaseWho this might be right forFabry Disease Guangzhou Jiayin Biotech Ltd 16
Not applicableStudy completedNCT01271699What this trial is testingPrevalence of Fabry Disease in a Defined Population at Risk - Patients Formerly Diagnosed With Multiple SclerosisWho this might be right forMultiple Sclerosis CENTOGENE GmbH Rostock 250
Not applicableLooking for participantsNCT03362164What this trial is testingEvaluation of HEArt invoLvement in Patients With FABRY DiseaseWho this might be right forRare DiseasesFabry DiseaseFabry Disease, Cardiac Variant+1 more Wuerzburg University Hospital 650
Not applicableLooking for participantsNCT06607471What this trial is testingMultimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.Who this might be right forNon-ischemic CardiomyopathyDilated Cardiomyopathy (DCM)Hypertrophic Cardiomyopathy (HCM)+12 more Scientific Institute San Raffaele 15,000
Not applicableStudy completedNCT04281537What this trial is testingDescribe the Experience of Both Patients and Their Clinicians in the Treatment of Fabry Disease With Enzyme Replacement Therapy.Who this might be right forFabry Disease Amicus Therapeutics 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT07716865What this trial is testingSafety, Tolerability and Efficacy of NPI-001 in Patients With Hereditary Cystatin C Amyloid Angiopathy (HCCAA)Who this might be right forHereditary Cystatin C Amyloid Angiopathy (HCCAA)Hemorrhage BrainHemorrhage Cerebral Arctic Therapeutics 15
Not applicableUnknownNCT02843334What this trial is testingStudy of the Prevalence of Fabry Disease in French Dialysis PatientsWho this might be right forFabry DiseaseEnd Stage Renal DiseaseRenal Dialysis Hospices Civils de Lyon 6,000
Not applicableStudy completedNCT01947634What this trial is testingSleepiness and Sleep-disordered Breathing in Fabry Disease. A Prospective Cohort Study.Who this might be right forFabry Disease University of Zurich 52
Not applicableStudy completedNCT01182818What this trial is testingFabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry DiseaseWho this might be right forCerebrovascular AccidentStroke, AcuteCerebral Stroke University of Rostock 1,000
Not applicableStudy completedNCT01560520What this trial is testingPhysical Activity Immediately After Acute Cerebral IschemiaWho this might be right forIschemic StrokePhysical Activity Hillerod Hospital, Denmark 100
Post-approval studies (Phase 4)Study completedNCT00097890What this trial is testingReplagal Enzyme Replacement Therapy for Adults With Fabry DiseaseWho this might be right forFabry Disease National Institute of Neurological Disorders and Stroke (NINDS) 25
Not applicableStudy completedNCT05714813What this trial is testingCircuit Training and RetinaWho this might be right forCognitive Impairment, ProgressiveCerebral Small Vessel Diseases University of Miami 40
Not applicableUnknownNCT05773235What this trial is testingMRI-markers to Monitor Small Vessel Disease Dynamics in the Prognosis of Small Vessel Disease-associated, Cerebrovascular EventsWho this might be right forIntracerebral HemorrhageCAA - Cerebral Amyloid AngiopathyCerebral Small Vessel Diseases Insel Gruppe AG, University Hospital Bern 60
Not applicableNo Longer AvailableNCT01370447What this trial is testingEPI-743 for Mitochondrial Respiratory Chain DiseasesWho this might be right forMitochondrial Diseases PTC Therapeutics
Large-scale testing (Phase 3)Looking for participantsNCT05710692What this trial is testingStudy to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry DiseaseWho this might be right forFabry Disease Chiesi Farmaceutici S.p.A. 16
Post-approval studies (Phase 4)Ended earlyNCT00230607What this trial is testingStudy of the Effects of Fabrazyme Treatment on Lactation and InfantsWho this might be right forFabry DiseaseAlpha Galactosidase A Deficiency Genzyme, a Sanofi Company 7
Not applicableStudy completedNCT03230149What this trial is testingPrevalence and Characteristics of Fabry Disease (FD) in Patients With Stroke or Small Fiber NeuropathyWho this might be right forFabry Disease Assistance Publique - Hôpitaux de Paris 379
Not applicableLooking for participantsNCT06663358What this trial is testingA Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry PatientsWho this might be right forFabry Disease Chiesi Farmaceutici S.p.A. 100